$PED
PEDEVCO CORP Stock $ped

$ped Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000165495423006582 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$10.91M	$8.164M	$7.090M
YoY Change	14.28%	15.15%	100.79%
Cost Of Revenue	$2.809M	$2.466M	$2.356M
YoY Change	0.25%	4.67%	83.2%
Gross Profit	$8.101M	$5.698M	$4.734M
YoY Change	20.1%	20.36%	110.87%
Gross Profit Margin	74.25%	69.79%	66.77%
Selling, General & Admin	$1.332M	$1.488M	$1.592M
YoY Change	2.78%	-6.53%	-9.9%
% of Gross Profit	16.44%	26.11%	33.63%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$3.235M	$2.581M	$1.886M
YoY Change	45.2%	36.85%	20.82%
% of Gross Profit	39.93%	45.3%	39.84%
Operating Expenses	$7.376M	$6.535M	$5.834M
YoY Change	16.6%	12.02%	26.44%
Operating Profit	$3.534M	$1.629M	$1.256M
YoY Change	9.72%	29.7%	73.96%
Interest Expense	$86.00K	$98.00K	$0.00
YoY Change			-100.0%
% of Operating Profit	2.43%	6.02%	0.0%
Other Income/Expense, Net	$86.00K	$133.0K	$83.00K
YoY Change	-881.82%	60.24%	1283.33%
Pretax Income	$3.620M	$1.762M	$1.339M
YoY Change	12.77%	31.59%	83.93%
Income Tax
% Of Pretax Income
Net Earnings	$3.620M	$1.762M	$1.339M
YoY Change	12.77%	31.59%	83.93%
Net Earnings / Revenue	33.18%	21.58%	18.89%
Basic Earnings Per Share	$0.04	$0.02	$0.02
Diluted Earnings Per Share	$0.04	$0.02	$0.02
COMMON SHARES
Basic Shares Outstanding	87.04M shares	87.04M shares	728.0 shares
Diluted Shares Outstanding	87.04M shares	86.72M shares	86.07M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.46M	$14.14M	$21.84M
YoY Change	-45.96%	-35.25%	17.83%
Cash & Equivalents	$12.46M	$14.14M	$25.13M
Short-Term Investments
Other Short-Term Assets	$50.00K	$149.0K	$217.0K
YoY Change	35.14%	-31.34%	223.88%
Inventory
Prepaid Expenses
Receivables	$6.441M	$5.788M	$3.970M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$18.96M	$20.08M	$26.02M
YoY Change	-32.02%	-22.86%	30.07%
LONG-TERM ASSETS
Property, Plant & Equipment	$87.00M	$84.24M	$71.83M
YoY Change	22.12%	17.27%	7.94%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$3.819M	$3.821M	$3.533M
YoY Change	8.34%	8.15%	-0.08%
Total Long-Term Assets	$90.82M	$88.06M	$75.37M
YoY Change	21.47%	16.84%	7.54%
TOTAL ASSETS
Total Short-Term Assets	$18.96M	$20.08M	$26.02M
Total Long-Term Assets	$90.82M	$88.06M	$75.37M
Total Assets	$109.8M	$108.1M	$101.4M
YoY Change	6.94%	6.65%	12.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.019M	$3.683M	$3.953M
YoY Change	3.77%	-6.83%	483.04%
Accrued Expenses	$1.322M	$1.375M	$1.327M
YoY Change	-13.43%	3.62%	132.4%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.072M	$6.767M	$6.288M
YoY Change	10.92%	7.62%	131.01%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$2.826M	$2.628M	$1.716M
YoY Change	57.17%	53.15%	-13.98%
Total Long-Term Liabilities	$2.826M	$2.628M	$1.716M
YoY Change	57.17%	53.15%	-14.88%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.072M	$6.767M	$6.288M
Total Long-Term Liabilities	$2.826M	$2.628M	$1.716M
Total Liabilities	$6.898M	$9.395M	$8.004M
YoY Change	26.13%	17.38%	68.93%
SHAREHOLDERS EQUITY
Retained Earnings	-$121.4M	-$125.0M
YoY Change	-2.94%
Common Stock	$87.00K	$87.00K
YoY Change	2.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$102.9M	$98.74M	$93.39M
YoY Change
Total Liabilities & Shareholders Equity	$109.8M	$108.1M	$101.4M
YoY Change	6.94%	6.65%	12.54%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$3.620M	$1.762M	$1.339M
YoY Change	12.77%	31.59%	83.93%
Depreciation, Depletion And Amortization	$3.235M	$2.581M	$1.886M
YoY Change	45.2%	36.85%	20.82%
Cash From Operating Activities	$6.592M	$1.782M	$1.415M
YoY Change	15.33%	25.94%	54.98%
INVESTING ACTIVITIES
Capital Expenditures	$8.267M	$17.07M	-$5.508M
YoY Change	-282.13%	-409.97%	846.39%
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$8.267M	-$17.07M	-$5.508M
YoY Change	82.13%	209.97%	-527.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000		0.000
YoY Change	-100.0%		-100.0%
NET CHANGE
Cash From Operating Activities	6.592M	$1.782M	$1.415M
Cash From Investing Activities	-8.267M	-$17.07M	-$5.508M
Cash From Financing Activities	0.000		0.000
Net Change In Cash	-1.675M	-$15.29M	-$4.093M
YoY Change	-236.51%	273.59%	-138.96%
FREE CASH FLOW
Cash From Operating Activities	$6.592M	$1.782M	$1.415M
Capital Expenditures	$8.267M	$17.07M	-$5.508M
Free Cash Flow	-$1.675M	-$15.29M	$6.923M
YoY Change	-116.33%	-320.87%	363.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001141197
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	85790267	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	87040267	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.00
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P2Y8M12D
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-35922
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	PEDEVCO Corp.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	TX
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	22-3755993
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	575 N. Dairy Ashford
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 210
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Houston
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77079
CY2023Q1	dei	City Area Code CityAreaCode	713
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	221-1768
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value per share
CY2023Q1	dei	Trading Symbol TradingSymbol	PED
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	87040267	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14139000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29430000	usd
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	5788000	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	2430000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	149000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	249000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	20076000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	32109000	usd
CY2023Q1	us-gaap	Oil And Gas Property Full Cost Method Gross OilAndGasPropertyFullCostMethodGross	82692000	usd
CY2022Q4	us-gaap	Oil And Gas Property Full Cost Method Gross OilAndGasPropertyFullCostMethodGross	79372000	usd
CY2023Q1	us-gaap	Oil And Gas Producing Properties Of Rate Regulated Companies Unamortized Cost OilAndGasProducingPropertiesOfRateRegulatedCompaniesUnamortizedCost	1500000	usd
CY2022Q4	us-gaap	Oil And Gas Producing Properties Of Rate Regulated Companies Unamortized Cost OilAndGasProducingPropertiesOfRateRegulatedCompaniesUnamortizedCost	775000	usd
CY2023Q1	us-gaap	Mineral Properties Net MineralPropertiesNet	84192000	usd
CY2022Q4	us-gaap	Mineral Properties Net MineralPropertiesNet	80147000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	45000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	71000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3821000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3783000	usd
CY2023Q1	us-gaap	Assets Assets	108134000	usd
CY2022Q4	us-gaap	Assets Assets	116110000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3683000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1556000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1375000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	13835000	usd
CY2023Q1	ped	Revenue Payable Current RevenuePayableCurrent	1000000	usd
CY2022Q4	ped	Revenue Payable Current RevenuePayableCurrent	1018000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	51000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	81000	usd
CY2023Q1	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	658000	usd
CY2022Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	472000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	6767000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16962000	usd
CY2023Q1	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	2628000	usd
CY2022Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	2689000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	9395000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	19651000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	87040267	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	85790267	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	87000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	86000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	223631000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	223114000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-124979000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-126741000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	98739000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	96459000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	108134000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	116110000	usd
CY2023Q1	ped	Oil And Gas Sales OilAndGasSales	8164000	usd
CY2022Q1	ped	Oil And Gas Sales OilAndGasSales	7090000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	2466000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	2356000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1488000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1592000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2581000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1886000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	6535000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	5834000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1629000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1256000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	98000	usd
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	3000	usd
CY2023Q1	us-gaap	Other Income OtherIncome	35000	usd
CY2022Q1	us-gaap	Other Income OtherIncome	80000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	133000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	83000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1762000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	1339000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	86720823	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	86066070	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	86720823	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	86066070	shares
CY2023Q1	us-gaap	Profit Loss ProfitLoss	1762000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	1339000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2581000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1886000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	26000	usd
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	24000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	518000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	563000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3358000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2188000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	100000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	109000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	35000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-94000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	136000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-243000	usd
CY2023Q1	ped	Increase Decrease Revenue Payable IncreaseDecreaseRevenuePayable	-18000	usd
CY2022Q1	ped	Increase Decrease Revenue Payable IncreaseDecreaseRevenuePayable	19000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1782000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1415000	usd
CY2023Q1	ped	Cash Paid For Drilling And Completion Costs CashPaidForDrillingAndCompletionCosts	-17032000	usd
CY2022Q1	ped	Cash Paid For Drilling And Completion Costs CashPaidForDrillingAndCompletionCosts	-5508000	usd
CY2023Q1	ped	Payment For Cash Paid For Vehicle PaymentForCashPaidForVehicle	-41000	usd
CY2022Q1	ped	Payment For Cash Paid For Vehicle PaymentForCashPaidForVehicle	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17073000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5808000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-15291000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-4093000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32977000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29227000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17686000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25134000	usd
CY2023Q1	us-gaap	Interest Paid InterestPaid	0	usd
CY2022Q1	us-gaap	Interest Paid InterestPaid	0	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023Q1	ped	Accrued Oil And Gas Development Costs AccruedOilAndGasDevelopmentCosts	10534000	usd
CY2022Q1	ped	Accrued Oil And Gas Development Costs AccruedOilAndGasDevelopmentCosts	173000	usd
CY2023Q1	us-gaap	Asset Retirement Obligation Revision Of Estimate AssetRetirementObligationRevisionOfEstimate	6000	usd
CY2022Q1	us-gaap	Asset Retirement Obligation Revision Of Estimate AssetRetirementObligationRevisionOfEstimate	45000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	96459000	usd
CY2023Q1	ped	Restricted Stock Issued During Period Value New Issues RestrictedStockIssuedDuringPeriodValueNewIssues	0	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	518000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	1762000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	98739000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	91483000	usd
CY2022Q1	ped	Restricted Stock Issued During Period Value New Issues RestrictedStockIssuedDuringPeriodValueNewIssues	0	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	563000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	1339000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	93385000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	8164000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7090000	usd
CY2022Q4	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	3547000	usd
CY2023Q1	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	3547000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	17686000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	32977000	usd
CY2023Q1	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	5000000.0	usd
CY2022Q4	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	0	usd
CY2022Q4	us-gaap	Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion And Amortization OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAndAmortization	176253000	usd
CY2023Q1	us-gaap	Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion And Amortization OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAndAmortization	182026000	usd
CY2022Q4	ped	Oil And Gas Property Successful Effort Method Not Accumulated Depreciation Depletion And Amortization OilAndGasPropertySuccessfulEffortMethodNotAccumulatedDepreciationDepletionAndAmortization	775000	usd
CY2023Q1	ped	Oil And Gas Property Successful Effort Method Not Accumulated Depreciation Depletion And Amortization OilAndGasPropertySuccessfulEffortMethodNotAccumulatedDepreciationDepletionAndAmortization	1500000	usd
CY2022Q4	ped	Asset Retirement Costs AssetRetirementCosts	1407000	usd
CY2023Q1	ped	Asset Retirement Costs AssetRetirementCosts	1401000	usd
CY2022Q4	us-gaap	Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion Amortization And Impairment OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAmortizationAndImpairment	98288000	usd
CY2023Q1	us-gaap	Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion Amortization And Impairment OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAmortizationAndImpairment	100735000	usd
CY2022Q4	us-gaap	Oil And Gas Property Full Cost Method Net OilAndGasPropertyFullCostMethodNet	80147000	usd
CY2023Q1	us-gaap	Oil And Gas Property Full Cost Method Net OilAndGasPropertyFullCostMethodNet	84192000	usd
CY2023Q1	ped	Capital Cost Of Drilling And Completion CapitalCostOfDrillingAndCompletion	4940000	usd
CY2023Q1	ped	Description Of Additional Acquired DescriptionOfAdditionalAcquired	The Company also acquired approximately 187 net mineral acres, and 1,523 net lease
CY2023Q1	ped	Cost Of Due Deligence CostOfDueDeligence	291000	usd
CY2022Q4	ped	Cost Of Due Deligence CostOfDueDeligence	1267000	usd
CY2023Q1	us-gaap	Depletion Depletion	2447000	usd
CY2022Q1	us-gaap	Depletion Depletion	1745000	usd
CY2023Q1	ped	Asset Retirement Obligations AssetRetirementObligations	3161000	usd
CY2023Q1	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	131000	usd
CY2023Q1	ped	Changes In Estimates Net ChangesInEstimatesNet	-6000	usd
CY2023Q1	ped	Asset Retirement Obligations Ending AssetRetirementObligationsEnding	3286000	usd
CY2022Q4	ped	Cureent Asset Retirement CureentAssetRetirement	472000000	usd
CY2023Q1	ped	Cureent Asset Retirement CureentAssetRetirement	658000000	usd
CY2023Q1	us-gaap	Other Expenses OtherExpenses	10000	usd
CY2023Q1	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2027-02-28
CY2023Q1	ped	Sale Leaseback Transaction Monthly Rentals Payments SaleLeasebackTransactionMonthlyRentalsPayments	9200	usd
CY2023Q1	ped	Base Monthly Rent Increased Amount BaseMonthlyRentIncreasedAmount	9500	usd
CY2023Q1	ped	Security Deposit And Prepaid Rent SecurityDepositAndPrepaidRent	14700	usd
CY2023Q1	ped	Supplemental Information Related To Operating Leasetabletextblock SupplementalInformationRelatedToOperatingLeasetabletextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td/><td colspan="4" style="BORDER-BOTTOM: #000000 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31, 2023</strong></p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash paid for amounts included in the measurement of lease liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">31</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Supplemental balance sheet information related to the Company’s operating sublease is included in the table below (in thousands):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31, 2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operating lease – right-of-use asset</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">45</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operating lease liabilities - current</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">51</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operating lease liabilities - long-term</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total lease liability</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">51</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	31000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	45000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	51000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	51000	usd
CY2023Q1	ped	Weighted Average Remaining Lease Term WeightedAverageRemainingLeaseTerm	P0Y4M24D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0535	pure
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	51000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	51000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	0	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	51000	usd
CY2023Q1	us-gaap	Other Commitments Description OtherCommitmentsDescription	In the Permian Basin Asset, 61 acres are due to expire during the remainder of 2023 and 40 net acres expire thereafter (net to our direct ownership interest only).
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1250000	shares
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	412000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	1829000	usd
CY2023Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	106000	usd
CY2023Q1	ped	Intrinsic Value Of Outstanding And Exercisable IntrinsicValueOfOutstandingAndExercisable	0	usd
CY2023Q1	ped	Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Numbers ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumbers	1407667	shares
CY2023Q1	ped	Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Weighted Average Exercise Price Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePriceEnding	1.51
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	540000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.09
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	21666	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	1.68
CY2023Q1	ped	Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber	1926001	shares
CY2023Q1	ped	Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice	1.39
CY2023Q1	ped	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2a SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2a	P3Y1M6D
CY2023Q1	ped	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Numbers ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumbers	949334	shares
CY2023Q1	ped	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Prices ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrices	1.63
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P2Y
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1762000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	1339000	usd
CY2023Q1	ped	Effect Of Exchange Rates On Cash And Cash Equivalents EffectOfExchangeRatesOnCashAndCashEquivalents	0	usd
CY2022Q1	ped	Effect Of Exchange Rates On Cash And Cash Equivalents EffectOfExchangeRatesOnCashAndCashEquivalents	0	usd
CY2023Q1	ped	Net Income Adjusted For Common Stock Equivalents NetIncomeAdjustedForCommonStockEquivalents	1762000	usd
CY2022Q1	ped	Net Income Adjusted For Common Stock Equivalents NetIncomeAdjustedForCommonStockEquivalents	1339000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	86720823	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	86066070	shares
CY2023Q1	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2022Q1	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	86720823	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	86066070	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2023Q1	ped	Share Equivalents Related To Options To Purchase Of Commmon Stock ShareEquivalentsRelatedToOptionsToPurchaseOfCommmonStock	1926001000	shares
CY2021Q1	ped	Share Equivalents Related To Options To Purchase Of Commmon Stock ShareEquivalentsRelatedToOptionsToPurchaseOfCommmonStock	1632668000	shares

Files In Submission

Name	View Source	Status
0001654954-23-006582-index-headers.html	Edgar Link	pending
0001654954-23-006582-index.html	Edgar Link	pending
0001654954-23-006582.txt	Edgar Link	pending
0001654954-23-006582-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
ped-20230331.xsd	Edgar Link	pending
ped_10q.htm	Edgar Link	pending
ped_10qimg1.jpg	Edgar Link	pending
ped_ex311.htm	Edgar Link	pending
ped_ex312.htm	Edgar Link	pending
ped_ex321.htm	Edgar Link	pending
ped_ex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ped-20230331_cal.xml	Edgar Link	unprocessable
ped-20230331_def.xml	Edgar Link	unprocessable
ped-20230331_lab.xml	Edgar Link	unprocessable
ped-20230331_pre.xml	Edgar Link	unprocessable
ped_10q_htm.xml	Edgar Link	completed
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PED
PEDEVCO CORP Stock $ped

2023 Q2 Form 10-Q Financial Statement

#000165495423006582 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PED PEDEVCO CORP Stock $ped

2023 Q2 Form 10-Q Financial Statement

#000165495423006582 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PED
PEDEVCO CORP Stock $ped